1. Home
  2. ARWR vs ACA Comparison

ARWR vs ACA Comparison

Compare ARWR & ACA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • ACA
  • Stock Information
  • Founded
  • ARWR 2003
  • ACA 2018
  • Country
  • ARWR United States
  • ACA United States
  • Employees
  • ARWR N/A
  • ACA N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • ACA Metal Fabrications
  • Sector
  • ARWR Health Care
  • ACA Industrials
  • Exchange
  • ARWR Nasdaq
  • ACA Nasdaq
  • Market Cap
  • ARWR 5.1B
  • ACA 4.2B
  • IPO Year
  • ARWR 1993
  • ACA N/A
  • Fundamental
  • Price
  • ARWR $39.24
  • ACA $93.62
  • Analyst Decision
  • ARWR Strong Buy
  • ACA Strong Buy
  • Analyst Count
  • ARWR 8
  • ACA 3
  • Target Price
  • ARWR $47.75
  • ACA $112.00
  • AVG Volume (30 Days)
  • ARWR 1.8M
  • ACA 183.3K
  • Earning Date
  • ARWR 11-25-2025
  • ACA 10-30-2025
  • Dividend Yield
  • ARWR N/A
  • ACA 0.21%
  • EPS Growth
  • ARWR N/A
  • ACA N/A
  • EPS
  • ARWR N/A
  • ACA 1.87
  • Revenue
  • ARWR $572,976,000.00
  • ACA $2,675,500,000.00
  • Revenue This Year
  • ARWR $21,287.22
  • ACA $12.65
  • Revenue Next Year
  • ARWR N/A
  • ACA $6.22
  • P/E Ratio
  • ARWR N/A
  • ACA $49.98
  • Revenue Growth
  • ARWR 2816.20
  • ACA 9.78
  • 52 Week Low
  • ARWR $9.57
  • ACA $68.11
  • 52 Week High
  • ARWR $40.48
  • ACA $113.43
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 65.60
  • ACA 51.38
  • Support Level
  • ARWR $36.73
  • ACA $91.72
  • Resistance Level
  • ARWR $40.48
  • ACA $95.33
  • Average True Range (ATR)
  • ARWR 1.70
  • ACA 2.27
  • MACD
  • ARWR -0.20
  • ACA 0.21
  • Stochastic Oscillator
  • ARWR 78.79
  • ACA 72.60

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About ACA Arcosa Inc.

Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.

Share on Social Networks: